Mar 2, 2023 Forbes Breaking News


The Food and Drug Administration turned down a bid from Neuralink, the ambitious yet controversial human brain chip startup founded by the nation’s richest man Elon Musk, to begin human trials, Reuters reported Thursday, a major setback for the ambitious yet controversial startup even as Musk claims Neuralink’s implants are safe enough for insertion into his and children’s brains.

Leave a Reply

Your email address will not be published. Required fields are marked *